Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/44R
Name: Drug, bio-affecting and body treating compositions >
Description:










Sub-classes under this class:

Class Number Class Name Patents
514/ Dermatitis 0
514/ Mouth treatment 0
514/ Liquid carrier, diluent or solvent 0
514/ Solid carrier or solid diluent 0
514/ Gaseous or gas emitting carrier or propellant 0
514/ Pill, lozenge, tablet or capsule 0
514/ Suppository, bougie or base 0
514/ Special designated ingredient 0
514/ Designated organic active ingredient containing (doai) 0
514/1 Designated organic active ingredient containing (doai) 691
514/769 Designated inorganic nonactive ingredient or elemental material other than water 191
514/772 Designated organic nonactive ingredient containing other than hydrocarbon 765
514/788.1 Solid synthetic organic polymer derived solely from hydrocarbon reactants as designated organic nonactive ingredient containing 33
514/789 Miscellaneous (e.g., hydrocarbons, etc.) 197
514/800 Lhrh like 204
514/801 Collagen, gelatin or derivatives thereof 217
514/802 Fibrinopeptides, blood-coagulation factors or derivatives 118
514/803 Kinin or derivatives 12
514/804 Phecmycin series or derivatives 5
514/805 Adrenocorticotropic hormone or derivatives 32
514/806 Somatostatin or derivatives 127
514/807 Oxytoxin, vasopressin or derivatives 62
514/808 Calcitonin or derivatives 63
514/809 Enkephalin or endorphin or derivatives 140
514/810 Addiction 103
514/814 Anemia 113
514/816 Anesthetic, general 110
514/817 Anesthetic, topical 147
514/818 Anesthetic, local 120
514/819 Antacid, oral 87
514/821 Antiarrhythmic 427
514/822 Anticoagulation 476
514/823 Antidote 89
514/824 Arteriosclerosis 630
514/825 Arthritis 719
514/826 Asthma 843
514/827 Astringent, nonfacial 24
514/829 Bite or sting 42
514/832 Blood substitute 179
514/833 Blood plasma extender 88
514/834 Coagulant 79
514/835 Caries 101
514/836 Chelate 231
514/837 Cholera 21
514/838 Cirrhosis 38
514/839 Contact lens treatment 126
514/841 Contraceptive 148
514/844 Cosmetic, facial 1,426
514/849 Cough and cold preparation 128
514/851 Cystic fibrosis 126
514/852 Dandruff 121
514/853 Decongestant 66
514/866 Diabetes 1,030
514/867 Diarrhea 206
514/868 Distemper 6
514/869 Diuretic 281
514/870 Edema 145
514/872 Emesis (motion sickness-nausea) 110
514/873 Emollient 260
514/874 Estrogenic agent (noncontraceptive) 70
514/875 Flea control 50
514/877 Gallstone 30
514/878 Geriatrics 65
514/880 Hair treatment (therapeutic-scalp) 469
514/882 Hemorrhoid preparation 68
514/883 Hodgkin's disease 29
514/884 Hypoglycemia 71
514/885 Immune response affecting drug 1,164
514/886 Inflammation, skin 545
514/888 Influenza 73
514/889 Interferon inducer 115
514/890 Irritant (e.g., tear gas, etc.) 7
514/891 Kidney stone 51
514/892 Laxative 93
514/893 Liver disorder 167
514/895 Malaria 94
514/896 Measles 11
514/898 Meningitis 14
514/899 Menstrual disorder 112
514/903 Multiple sclerosis 186
514/904 Multiple vitamins 131
514/906 Muscle relaxant 205
514/907 Muscular dystrophy 29
514/908 Leukemia 345
514/909 Obesity 334
514/912 Ophthalmic 1,056
514/916 Pyretic 138
514/917 Radioactive, anti- 35
514/918 Repellent 79
514/921 Shock 140
514/922 Side effect reduction by incorporation of a second designated ingredient 243
514/923 Sleep aid (insomnia) 96
514/924 Tuberculosis 50
514/925 Ulcer treatment 354
514/929 Vasodilator 426
514/930 Vasoconstrictor (nondecongestant) 60
514/931 Veneral disease 80
514/935 Uterine motility 41
514/936 Dmso containing 61
514/937 Dispersion or emulsion 1,385
514/944 Gel 1,196
514/945 Foam 230
514/946 Penetrant or absorbent (enhances penetration into subject treated) 399
514/948 Solid candy type 78
514/949 Naturally derived clay (e.g., bentonite, etc.) 75
514/950 Macromolecular (other than synthetic resins) 44
514/951 Powders, granules or particles of specified mesh or particle size 497
514/953 Shaped forms adapted for noningestible use other than suppository type (e.g., films, inserts, etc.) 171
514/957 Vapor emmitting composition 79
514/958 For smoking or inhaling 191
514/959 Breathing gases 53
514/960 Significant, tablet formulation (e.g., designated excipient, disintegrant, glydent or lubricant, etc.) 472
514/962 Capsule (e.g., gelatin, etc.) 314
514/964 Sustained or differential release type 328
514/966 Rectal 148
514/967 Vaginal 170
514/968 Urethral 42
514/969 Ointment or salve base 371
514/970 Containing designated ingredient to stabilize an active ingredient 516
514/974 Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.) 269
514/975 Characterized by the designated surfactant used 371


Patents under this class:

Patent Number Title Of Patent Date Issued
8710026 MiR 204, miR 211, their anti-miRs, and therapeutic uses of same Apr. 29, 2014
8710025 Modified and stabilized GDF propeptides and uses thereof Apr. 29, 2014
8709997 Prevention and treatment of osteoarthritis Apr. 29, 2014
8709812 Drug comprising as the active ingredient proliferative vector containing survivin promoter Apr. 29, 2014
8709448 Anti-infective agents and uses thereof Apr. 29, 2014
8703733 Humanized TTC and methods of use thereof Apr. 22, 2014
8703142 Methods to bypass CD4+ cells in the induction of an immune response Apr. 22, 2014
8691784 MCP-1 binding nucleic acids Apr. 8, 2014
8691533 Inducible gene expression Apr. 8, 2014
8691208 Compositions and methods for treating hypophosphatasia Apr. 8, 2014
8685939 Vaccine targeting cellular death receptor DR5 Apr. 1, 2014
8685937 Nucleic acid aptamers Apr. 1, 2014
8685416 Compositions and methods for the treatment of cancer Apr. 1, 2014
8685387 Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 Apr. 1, 2014
8680069 Modified polynucleotides for the production of G-CSF Mar. 25, 2014
8680068 Herpes virus strains Mar. 25, 2014
8680064 ShRNA gene therapy for treatment of ischemic heart disease Mar. 25, 2014
8680062 System for delivering therapeutic agents into living cells and cells nuclei Mar. 25, 2014
8679542 Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus Mar. 25, 2014
8679477 Use of SDF-1 to mitigate scar formation Mar. 25, 2014
8673870 Combined DNA vaccine and biological modifiers for cancer therapy Mar. 18, 2014
8673859 GM-CSF cosmeceutical compositions and methods of use thereof Mar. 18, 2014
8673855 Phosphatidylinositol 3-kinases activity regulator including the fifth zinc finger domain of FOG2 Mar. 18, 2014
8673285 Sphingoid polyalkylamine conjugates for vaccination Mar. 18, 2014
8669237 Biodegradable immunomodulatory formulations and methods for use thereof Mar. 11, 2014
8669235 Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b Mar. 11, 2014
8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein Mar. 11, 2014
8664194 Method for producing a protein of interest in a primate Mar. 4, 2014
8663637 Methods and compositions for modulation of Olfml3 mediated angiogenesis Mar. 4, 2014
8658612 Therapeutic agent for malignant mesothelioma and immunostimulant Feb. 25, 2014
8658611 Apoptosis-inducing agent for prostate cancer cells Feb. 25, 2014
8658610 Replication-competent anti-cancer vectors Feb. 25, 2014
8658609 Modulation of bio-electrical rhythms via a novel engineering approach Feb. 25, 2014
8658607 Immunostimulatory G, U-containing oligoribonucleotides Feb. 25, 2014
8658507 MOSFET structure and method of fabricating the same using replacement channel layer Feb. 25, 2014
8658204 Transpulmonary liposome for controlling drug arrival Feb. 25, 2014
8653046 Controlling transgene expression across the skin Feb. 18, 2014
8653045 Induction of thyroid iodide-handling gene expression in human cancers Feb. 18, 2014
8652524 Organ regeneration device Feb. 18, 2014
8652504 Solid polymer delivery compositions and methods for use thereof Feb. 18, 2014
8648051 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin Feb. 11, 2014
8647863 Minicircle vector production Feb. 11, 2014
8642570 ASLV vector system Feb. 4, 2014
8642564 Compositions for drug administration Feb. 4, 2014
8642341 Materials and methods for gene mediated therapy of psychiatric disorders Feb. 4, 2014
8642045 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method usi Feb. 4, 2014
8637479 Compounds and methods for the treatment of inflammatory diseases of the CNS Jan. 28, 2014
8637006 Recombinant vaccines and use thereof Jan. 28, 2014
8629107 Genes and proteins associated with angiogenesis and uses thereof Jan. 14, 2014
8628785 Method for augmenting the immunogenicity of an antigen Jan. 14, 2014











 
 
  Recently Added Patents
Method for selective deposition of a semiconductor material
Progressively discovering and integrating services
Treatment of influenza
Wafer processing method and system using multi-zone chuck
Pickup device and method for manufacturing the same
Vehicle running control system
Measurement of an analyte on the skin using a hue angle
  Randomly Featured Patents
Suction punch
High resolution distance measuring apparatus
Apparatus and method for storing and reading digital images
Tire for a vehicle wheel
Electrical receptacle with power indicator light
Automotive windshield for a head up display system
Primerless urethane adhesive compositions
Epitaxial growth of dissimilar materials
Immobilized Lewis acid catalysts
Denaturants for sympathomimetic amine salts